{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036060","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2024-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.467438+00:00","generated_at":"2026-05-31T05:22:38.078087+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AIM ImmunoTech amends CEO/COO employment: CEO salary $650k plus $100k stock","bullets":["CEO Equels: cash salary reduced to $650,000, plus $100,000 in restricted shares for one year ending Sept 11, 2025.","COO Rodino: base salary $375,000 plus $50,000 in shares; period corrected to one year ending Aug 12, 2025.","Amendment corrects prior duration error in August 2024 compensation changes for both officers.","Shares valued at 100% of Sept 10, 2024 closing price; compensation committee approved the revisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036060","json":"https://secwatch.observer/filing/0001493152-24-036060.json","markdown":"https://secwatch.observer/filing/0001493152-24-036060.md","text":"https://secwatch.observer/filing/0001493152-24-036060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/0001493152-24-036060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315224036060/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:22:38.078087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}